Noam Levaot

POB 653, Ben Gurion Ave
Beersheba, D 84105, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Multi-specific targeting of CD44 and the catalytic and hemopexin domains of MMP9 as a therapeutic strategy for osteoclast inhibition.

Multi-specific targeting of CD44 and the catalytic and hemopexin domains of MMP9 as a therapeutic strategy for osteoclast inhibition.

Journal: New biotechnology

Published: March 01, 2026

Comparative analysis of osteoclast function in symptomatic and asymptomatic individuals with cherubism-causing SH3BP2 mutation.

Comparative analysis of osteoclast function in symptomatic and asymptomatic individuals with cherubism-causing SH3BP2 mutation.

Journal: JBMR plus

Published: March 24, 2025

The Role of GPR39 in Regulating Osteoblast Function, Bone Matrix Quality, and Gender-Specific Bone Homeostasis.

The Role of GPR39 in Regulating Osteoblast Function, Bone Matrix Quality, and Gender-Specific Bone Homeostasis.

Journal: Journal of cellular physiology

Published: February 10, 2025

Development and Application of Small Molecule-Peptide Conjugates as Cathepsin K-Specific Covalent Irreversible Inhibitors in Human Osteoclast and Lung Cancer.

Development and Application of Small Molecule-Peptide Conjugates as Cathepsin K-Specific Covalent Irreversible Inhibitors in Human Osteoclast and Lung Cancer.

Journal: JACS Au

Published: September 11, 2024

Mapping the sclerostin-LRP4 binding interface identifies critical interaction hotspots in loops 1 and 3 of sclerostin.

Mapping the sclerostin-LRP4 binding interface identifies critical interaction hotspots in loops 1 and 3 of sclerostin.

Journal: FEBS letters

Published: July 03, 2024

Preventing osteoporotic bone loss in mice by promoting balanced bone remodeling through M-CSFRGD, a dual antagonist to c-FMS and αvβ3 receptors.

Preventing osteoporotic bone loss in mice by promoting balanced bone remodeling through M-CSFRGD, a dual antagonist to c-FMS and αvβ3 receptors.

Journal: International journal of biological macromolecules

Published: June 23, 2024

SMARCA4 mutation causes human otosclerosis and a similar phenotype in mice.

SMARCA4 mutation causes human otosclerosis and a similar phenotype in mice.

Journal: Journal of medical genetics

Published: March 08, 2023

Competitive blocking of LRP4-sclerostin binding interface strongly promotes bone anabolic functions.

Competitive blocking of LRP4-sclerostin binding interface strongly promotes bone anabolic functions.

Journal: Cellular and molecular life sciences : CMLS

Published: September 02, 2021

Editorial: Developmental Biology and Regulation of Osteoclasts.

Editorial: Developmental Biology and Regulation of Osteoclasts.

Journal: Frontiers in cell and developmental biology

Published: September 01, 2021

Specific inflammatory osteoclast precursors induced during chronic inflammation give rise to highly active osteoclasts associated with inflammatory bone loss.

Specific inflammatory osteoclast precursors induced during chronic inflammation give rise to highly active osteoclasts associated with inflammatory bone loss.

Journal: Bone research

Published: October 08, 2020

Positive Outcomes of Denosumab Treatment in 2 Patients With Cherubism.

Positive Outcomes of Denosumab Treatment in 2 Patients With Cherubism.

Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons

Published: December 10, 2019

Reconstruction of the ovary microenvironment utilizing macroporous scaffold with affinity-bound growth factors.

Reconstruction of the ovary microenvironment utilizing macroporous scaffold with affinity-bound growth factors.

Journal: Biomaterials

Published: October 21, 2018

Showing 1-12 of 20

Last Updated: 09/26/2026